Nafiseh Esmaili
-
- Autoimmune Bullous Skin Diseases 20
- Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 12
- Rheumatology top 2%
- Urticaria and Related Conditions 12
- Hematology top 10%
- Platelet Disorders and Treatments 4
- Pharmacy top 10%
-
- Drug-Induced Adverse Reactions 2
-
- Cutaneous lymphoproliferative disorders research 2
-
- Mast cells and histamine 2
-
- Bioactive Compounds and Antitumor Agents 1
- Co-authors
- Cheyda Chams‐DavatchiMaryam DaneshpazhoohMahin ValikhaniZahra HallajiHossein MortazaviKamran BalighiSaeed GhodsiZ Safaei Naraghi
- Journals
- SHILAP Revista de lepidopterología (1 paper)Journal of the American Academy of Dermatology (2 papers)BMC Cancer (1 paper)
In The Last Decade
Nafiseh Esmaili
29 papers receiving 758 citations
Peers
Comparison fields: 5 of 69
- Pathology and Forensic Medicine 647
- Genetics 381
- Rheumatology 422
- Hematology 123
- Pharmacy 35
Countries citing papers authored by Nafiseh Esmaili
This map shows the geographic impact of Nafiseh Esmaili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nafiseh Esmaili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nafiseh Esmaili more than expected).
Fields of papers citing papers by Nafiseh Esmaili
This network shows the impact of papers produced by Nafiseh Esmaili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nafiseh Esmaili. The network helps show where Nafiseh Esmaili may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nafiseh Esmaili, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 5 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 7 | |
| 6 | 2019 | 9 | |
| 7 | 2019 | 35 | |
| 8 | 2018 | 10 | |
| 9 | The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. | 2014 | 20 |
| 10 | 2013 | 21 | |
| 11 | Pemphigus vulgaris activity score and assessment of convergent validity. | 2013 | 11 |
| 12 | 2011 | 68 | |
| 13 | 2011 | 35 | |
| 14 | 2011 | 15 | |
| 15 | 2010 | 21 | |
| 16 | 2008 | 25 | |
| 17 | 2008 | 22 | |
| 18 | 2007 | 125 | |
| 19 | 2007 | 30 | |
| 20 | 2005 | 167 |
About Nafiseh Esmaili
Nafiseh Esmaili is a scholar working on Genetics, Pathology and Forensic Medicine and Rheumatology, having authored 29 papers that have together received 772 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (20 papers), Urticaria and Related Conditions (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Platelet Disorders and Treatments (4 papers), Drug-Induced Adverse Reactions (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Mast cells and histamine (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (647 citations), Genetics (381 citations) and Rheumatology (422 citations). Nafiseh Esmaili has collaborated with scholars based in Iran, Iraq and France. Frequent co-authors include Cheyda Chams‐Davatchi, Maryam Daneshpazhooh, Mahin Valikhani, Zahra Hallaji, Hossein Mortazavi, Kamran Balighi, Saeed Ghodsi, Z Safaei Naraghi, Maryam Akhyani and Zahra Ghodsi. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.